Pear Therapeutics, Inc.: cashflow_operating

Value{"amount": -803868, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"}
Period2020-09-02 – 2021-03-31
Statuscurrent
EntityPear Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-21-170643 · Open the official SEC filing →
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001835567/cashflow-operating/2021-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a37d90ee-7961-474d-911b-47ff4b04e6bc

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies